archTIS delivered a sharp step-up in revenue and recurring income after acquiring Spirion, but the stronger top line came with a $16 million loss and a formal warning over its ability to fund operations. The cybersecurity company now has until late October to extend or refinance a key lending facility.
- Revenue rose 119.9% to $13.35 million
- ARR increased 208% to $14.8 million after the Spirion acquisition
- Net operating cash outflow reached $15.36 million
- Auditor highlighted a material uncertainty over going concern
- $3.2 million Australian Defence contract secured after year-end
Record recurring revenue meets a cash-flow squeeze
archTIS Limited (ASX:AR9) finished FY2026 with the shape of a much larger software business, but not yet the balance sheet to match it. Revenue nearly doubled to $13.35 million and annual recurring revenue jumped 208% to $14.8 million after the acquisition of US data-security company Spirion. At the same time, the group recorded a $15.997 million net loss and used $15.36 million in operating cash.
The numbers capture the central tension in the annual report: growth is arriving, but so are the costs of absorbing a significantly expanded operation. The company’s current liabilities of $18.56 million exceeded current assets of $8.08 million at 30 June, while cash stood at $2.86 million. RSM Australia Partners issued an unmodified audit opinion, but highlighted a “material uncertainty” that may cast significant doubt on archTIS’ ability to continue as a going concern.
Spirion reshapes the revenue base
Spirion added more than 150 recurring customers and pushed archTIS’ combined customer base to 225 organisations across the US, Australia, the UK, Europe and Asia. The acquisition also shifted the geographic mix: US revenue rose to $8.29 million from $720,489 a year earlier, while Australian revenue declined to $5.07 million from $5.35 million.
Licensing revenue rose to $11.72 million from $4.18 million and represented the clear majority of sales. Gross margin remained high at 74%, close to 76% in FY2025, while deferred revenue increased 40% to $8.54 million. Management has identified a $2 million cross-sell and upsell pipeline across the combined customer base, although the report says conversion remains dependent on execution.
Defence progress is substantial but not yet a funding solution
archTIS says NC Protect passed all 60 test cases in final US Department of Defense Warfighter Command production testing, with no technical barriers to deployment identified. That clears an important technical hurdle, but it does not constitute an award: licence discussions remain subject to US government procurement processes, and the timing and scale of any contract remain uncertain.
The Australian Defence relationship provides firmer near-term support. After year-end, archTIS secured a $3.2 million, 12-month Kojensi contract beginning 1 July 2026, comprising $1 million of recurring software licences and $2.2 million of application development and maintenance services. The deal includes options for two further 12-month extensions, but only the initial term is secured in the filing.
October debt deadline sharpens the near-term question
The company’s financial statements were prepared on a going-concern basis, relying on forecast operating cash flows, cost reductions, revenue receipts and continued access to funding. archTIS had used essentially all of its $8 million bank facility at year-end, leaving just $92, and subsequently negotiated an extension of a $4 million Commonwealth Bank lending facility to 30 October 2026.
Management says quarterly operating expenses fell in each of the final two quarters, including an 11% reduction in the June quarter, as it began realising a targeted $4.5 million in annualised Spirion synergies. The next test is whether those savings and the enlarged recurring revenue base can reduce cash burn quickly enough to address the funding uncertainty before the extended facility reaches maturity.
Bottom Line?
archTIS has built a materially larger recurring-revenue platform, but the October lending deadline means execution on cash generation matters as much as further sales growth.
Questions in the middle?
- Can the company convert its recurring revenue growth and cost synergies into materially lower operating cash outflows?
- Will the $4 million lending facility be refinanced or extended beyond 30 October 2026?
- How large and how soon could a US Department of Defense licence award become if procurement discussions progress?